Aytu BioPharma Inc. (AYTU)
1.24
0.00 (0.40%)
At close: Mar 27, 2025, 3:52 PM
1.25
0.80%
After-hours: Mar 27, 2025, 07:55 PM EDT
Aytu BioPharma Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 |
| Revenue | 81M | 107.4M | 96.67M | 65.63M | 27.63M | 7.32M | 3.66M | 3.22M | 2.56M | 261.78K | 58.93K | 1.75K | 1.75K | n/a | n/a | 1.75K | n/a | n/a |
| Cost of Revenue | 26.42M | 40.77M | 44.39M | 36.43M | 7.55M | 2.2M | 2.05M | 1.42M | 957.08K | 88.11K | n/a | -48.25K | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit | 54.59M | 66.63M | 52.28M | 29.2M | 20.08M | 5.12M | 1.61M | 1.8M | 1.61M | 173.67K | 58.93K | 50K | 1.75K | n/a | n/a | 1.75K | n/a | n/a |
| Operating Income | -5.25M | -17.07M | 37.22M | -38.24M | -20.94M | -16.85M | -19.7M | -20.13M | -21.7M | -7.63M | -6.35M | -52.41K | -56.36K | -133.62K | -56.74K | -55.82K | -54.98K | -46.89K |
| Interest Income | n/a | 9K | 14K | 6K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -14.08M | -17.05M | -110.28M | -58.03M | -13.62M | -27.13M | -10.19M | -22.51M | -28.18M | -7.75M | -6.39M | -57.32K | -59.67K | -136.8K | -56.47K | -58.89K | -48.95K | -48.95K |
| Net Income | -15.84M | -17.05M | -108.78M | -58.29M | -13.62M | -47.17M | -10.19M | -22.51M | -28.18M | -7.72M | -5.58M | -57.32K | -59.67K | -136.8K | -60.27K | -58.89K | -57.17K | -48.95K |
| Selling & General & Admin | 49.47M | 70.08M | 69.88M | 55.81M | 34.8M | 19.24M | 17.73M | 17.61M | 8.83M | 4.38M | 2.35M | 47.98K | 58.11K | 129.37K | 54.16K | 54.86K | 54.98K | 46.89K |
| Research & Development | 2.79M | 4.09M | 14.44M | 5.62M | 1.72M | 589.07K | 167.59K | 1.35M | 6.32M | 3.42M | 4.06M | 2.76M | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Expenses | 7.58M | -4.78M | 4.07M | 6.01M | 4.49M | 2.14M | 6.28M | 1.71M | 664.71K | 4.89K | 6.18K | 6.18K | 7.34K | 4.25K | 2.58K | 2.71K | n/a | n/a |
| Operating Expenses | 60.57M | 78.96M | 88.39M | 67.44M | 41.01M | 21.96M | 19.45M | 20.66M | 15.81M | 7.81M | 6.41M | 54.16K | 58.11K | 133.62K | 56.74K | 57.57K | 54.98K | 46.89K |
| Interest Expense | 4.79M | n/a | 147.5M | n/a | n/a | n/a | 749.42K | 2.53M | 5.49M | 114.99K | 45.55K | 4.9K | 3.32K | 3.18K | 3.8K | 3.07K | n/a | 2.06K |
| Selling & Marketing Expenses | 26.96M | 41.45M | 38.71M | 30.31M | 11.4M | n/a | n/a | -242 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 86.26M | 119.73M | 132.77M | 103.87M | 48.57M | 24.17M | 21.5M | 22.08M | 16.77M | 7.89M | 6.41M | 54.16K | 58.11K | 133.62K | 56.74K | 57.57K | 54.98K | 46.89K |
| Income Tax | 1.77M | -57K | -110K | 259K | -9.92M | 20.04M | -2.13M | 1.11M | 8.48M | -23.91K | -813.7K | 911.3K | 3.32K | 3.18K | -548 | 3.07K | 2.19K | 2.06K |
| Shares Outstanding (Basic) | 5.54M | 3.34M | 1.47M | 840K | 230K | 38.97K | 3.33K | 116.51 | 21.77 | 14.00 | 9.00 | 8.00 | 8.00 | 8.00 | 6.00 | 5.00 | 5.00 | 1.00 |
| Shares Outstanding (Diluted) | 5.54M | 3.34M | 1.47M | 840K | 230K | 38.97K | 3.33K | 116.51 | 21.77 | 14.00 | 9.00 | 8.00 | 8.00 | 8.00 | 6.00 | 5.00 | 5.00 | 1.00 |
| EPS (Basic) | -2.86 | -5.11 | -74.01 | -69.6 | -60.2 | -1.21K | -3.06K | -193.19K | -1.29M | -551.67K | -619.85K | -7.16K | -7.46K | -17.1K | -10.04K | -11.78K | -11.43K | -48.95K |
| EPS (Diluted) | -2.86 | -5.11 | -74.01 | -69.6 | -60.2 | -1.21K | -3.06K | -193.19K | -1.29M | -551.67K | -619.85K | -7.16K | -7.46K | -17.1K | -10.04K | -11.78K | -11.43K | -48.95K |
| EBITDA | -1.01M | -3.51M | -27.96M | -29.04M | -12.21M | -14.12M | -15.25M | -18.13M | -21.81M | -7.51M | -52.71K | -47.47K | -50.21K | -126.86K | -47.28K | -47.54K | -47.47K | -40.47K |
| Depreciation & Amortization | 8.27M | 8.81M | 10.15M | 7.7M | 4.59M | 2.24M | 1.85M | 1.84M | 874.79K | 118.2K | 97.48K | 4.94K | 6.15K | 6.76K | 9.19K | 8.28K | 7.51K | 6.42K |